Infinant Health

Infinant Health (formerly Evolve Biosystems) is a privately held life-sciences company in Sacramento, California, spun out of the Foods for Health Institute at the University of California, Davis after more than a decade of research into the infant gut microbiome. Its foundational discovery is B. infantis EVC001, a strain of Bifidobacterium longum subsp. infantis that metabolizes human milk oligosaccharides and has largely disappeared from infants in industrialized countries. The company commercializes that strain as Evivo, a consumer infant probiotic sold direct-to-consumer and through retail, and is developing INF108 as a drug candidate intended to reduce necrotizing enterocolitis in premature infants. Infinant Health is a biotechnology and consumer-health manufacturer rather than a software company: it publishes clinical trials, peer-reviewed publications and investor material, but no developer program, public API, SDK or machine-readable API contract could be found on any of its hosts.

Infinant Health is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Health, and Infant Nutrition.

Infinant Health’s developer surface includes engineering blog, support, and 11 more developer resources.

12.2/100 minimal ▬ flat Agent 3/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesHealthInfant NutritionMicrobiomeProbioticsConsumer HealthPharmaceuticalsClinical Research

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 12.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 1.1 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 3/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 7 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/evolve-biosystems: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Pricing Plans 1

Published pricing tiers and plan structures.

Rate Limits 1

Documented rate limits and quota policies.

Evolve Biosystems Rate Limits

0 limits

RATE LIMITS

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Evolve Biosystems Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 3

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: evolve-biosystems
name: Infinant Health
description: 'Infinant Health (formerly Evolve Biosystems) is a privately held life-sciences company in Sacramento, California,
  spun out of the Foods for Health Institute at the University of California, Davis after more than a decade of research into
  the infant gut microbiome. Its foundational discovery is B. infantis EVC001, a strain of Bifidobacterium longum subsp. infantis
  that metabolizes human milk oligosaccharides and has largely disappeared from infants in industrialized countries. The company
  commercializes that strain as Evivo, a consumer infant probiotic sold direct-to-consumer and through retail, and is developing
  INF108 as a drug candidate intended to reduce necrotizing enterocolitis in premature infants. Infinant Health is a biotechnology
  and consumer-health manufacturer rather than a software company: it publishes clinical trials, peer-reviewed publications
  and investor material, but no developer program, public API, SDK or machine-readable API contract could be found on any
  of its hosts.'
url: https://raw.githubusercontent.com/api-evangelist/evolve-biosystems/refs/heads/main/apis.yml
image: https://www.infinanthealth.com/hs-fs/hubfs/Infinant_logo_K_no_mark_new.png?width=500&height=250&name=Infinant_logo_K_no_mark_new.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Life Sciences
- Health
- Infant Nutrition
- Microbiome
- Probiotics
- Consumer Health
- Pharmaceuticals
- Clinical Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evolve-biosystems-domain-security.yml
- type: Website
  url: https://www.infinanthealth.com/
- type: Blog
  url: https://www.infinanthealth.com/blog
- type: Support
  url: https://www.infinanthealth.com/contact-us
- type: TermsOfService
  url: https://www.infinanthealth.com/terms-of-service
- type: PrivacyPolicy
  url: https://www.infinanthealth.com/privacy
- type: Newsletter
  url: https://www.infinanthealth.com/newsletter-subscribe
- type: Press
  url: https://www.infinanthealth.com/press
- type: Investors
  url: https://www.infinanthealth.com/for-investors
- type: SecondaryMarket
  url: https://forgeglobal.com/evolve-biosystems_stock/
- type: LLMsTxt
  url: llms/evolve-biosystems-llms.txt
- type: Plans
  url: plans/evolve-biosystems-plans-pricing.yml
- type: RateLimits
  url: rate-limits/evolve-biosystems-rate-limits.yml
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 5
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Infinant Health is a UC Davis infant-microbiome biotech that sells the Evivo probiotic and develops the INF108 drug
    candidate; its only web properties are a HubSpot marketing site and a WordPress consumer store, and api./developer./docs.
    infinanthealth.com do not resolve in DNS at all.
  evidence:
  - url: https://www.infinanthealth.com/openapi.json
    status: 404
  - url: https://www.infinanthealth.com/.well-known/agent-card.json
    status: 404
  - url: https://www.infinanthealth.com/llms.txt
    status: 404
  - url: https://www.evivo.com/openapi.json
    status: 404
  - url: https://api.github.com/orgs/infinanthealth
    status: 404
  checked: '2026-08-12'